Abbott will acquire Exact Sciences for $21 billion
Abbott and Exact Sciences, which does research at TGen in the Phoenix Bioscience Core, today announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to…
NeuroCatch Inc., a brain health technology company based out of British Columbia, announced today it will open its United States headquarters in Greater Phoenix at the Phoenix Bioscience Core (PBC).…
Mixing is vital in laboratories, whether for scientific applications or industrial functions. It’s the way we combine things and maintain reactions. How you stir things really changes how things turn…
A new blueprint for Arizona’s emerging bioscience ecosystem lays out a plan for the state to capitalize on more than two decades of momentum and become a nationally recognized leader…
Researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, and the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center have identified a potential biomarker for long COVID. If…
Efficiency in clinical research is no longer just a goal; it’s a necessity. As the demand for faster, more precise, and patient-centered treatments grows, traditional clinical trial models are being…
Discovering a personal energetic blueprint can feel simple with clear instructions. In just a few minutes, you can go from entering basic birth details to seeing your unique Human Design…
The return of dire wolves to the modern world carries profound cultural and spiritual significance for Indigenous communities whose ancestors lived alongside these magnificent predators for thousands of years. Colossal…
Arizona continues to outpace the nation in several key bioscience industry and innovation ecosystem metrics, including gains in jobs and academic R&D expenditures. Still, challenges remain in the areas of…
The successful resurrection of the dire wolf marks a historic milestone for Colossal Biosciences, but it represents just the beginning of the company’s ambitious vision. Founded in 2021 with the…
CRISPR screening has revolutionized biomedical research by enabling precise, high-throughput interrogation of gene functions. This technology facilitates the identification of disease mechanisms and therapeutic targets, paving the way for advancements…
Arizona bioscience companies Anuncia Medical and Macula Vision Systems have been selected from a competitive field of startups to receive funding support through the 2025 Flinn Foundation Bioscience Entrepreneurship Program.…